Charlotte Schutz
Overview
Explore the profile of Charlotte Schutz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Syarif O, Oladele R, Gils T, Rajasingham R, Falconer J, Achii P, et al.
Lancet Glob Health
. 2024 Nov;
13(1):e16-e18.
PMID: 39491054
No abstract available.
2.
Walker N, Schutz C, Ward A, Barr D, Opondo C, Shey M, et al.
J Infect Dis
. 2024 Sep;
231(1):109-114.
PMID: 39219411
Mortality from human immunodeficiency virus (HIV)-associated tuberculosis (TB) is high, particularly among hospitalized patients. In 433 people with HIV hospitalized with symptoms of TB, we investigated plasma matrix metalloproteinases (MMP)...
3.
Namale P, Boloko L, Vermeulen M, Haigh K, Bagula F, Maseko A, et al.
Trials
. 2024 May;
25(1):311.
PMID: 38720383
Background: HIV-associated tuberculosis (TB) contributes disproportionately to global tuberculosis mortality. Patients hospitalised at the time of the diagnosis of HIV-associated disseminated TB are typically severely ill and have a high...
4.
Abdelgawad N, Chirehwa M, Schutz C, Barr D, Ward A, Janssen S, et al.
Wellcome Open Res
. 2024 Mar;
7:72.
PMID: 37008250
Background: Early mortality among hospitalized HIV-associated tuberculosis (TB/HIV) patients is high despite treatment. The pharmacokinetics of rifampicin, isoniazid, and pyrazinamide were investigated in hospitalized TB/HIV patients and a cohort of...
5.
Stek C, Shey M, Mnika K, Schutz C, Thienemann F, Wilkinson R, et al.
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad379.
PMID: 37520416
The development of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) and its prevention using prednisone may potentially be mediated by the genotype. We assessed this hypothesis in a clinical trial...
6.
Shey M, Balfour A, Masina N, Bekiswa A, Schutz C, Goliath R, et al.
Front Immunol
. 2023 Jun;
14:1176615.
PMID: 37275871
Background: Currently, diagnosis of latent TB infection (LTBI) is based on the secretion of IFN-γ in response to (Mtb) antigens, the absence of which is regarded as no infection. Some...
7.
Araujo-Pereira M, Schutz C, Barreto-Duarte B, Barr D, Villalva-Serra K, Vinhaes C, et al.
Front Immunol
. 2023 May;
14:1177432.
PMID: 37143662
Introduction: Anemia frequently affects people living with HIV (PLHIV). Nevertheless, the impact of anemia on treatment outcomes of patients with HIV-associated tuberculosis (TB) and the underlying molecular profiles are not...
8.
Lawrence D, Muthoga C, Meya D, Tugume L, Williams D, Rajasingham R, et al.
Lancet Glob Health
. 2022 Nov;
10(12):e1845-e1854.
PMID: 36400090
Background: HIV-associated cryptococcal meningitis is a leading cause of AIDS-related mortality. The AMBITION-cm trial showed that a regimen based on a single high dose of liposomal amphotericin B deoxycholate (AmBisome...
9.
Spies R, Schutz C, Ward A, Balfour A, Shey M, Nicol M, et al.
South Afr J HIV Med
. 2022 Oct;
23(1):1396.
PMID: 36299556
Background: Patients with HIV and drug-resistant tuberculosis (TB) are at high risk of death. Objectives: We investigated the association between rifampicin-resistant TB (RR-TB) and mortality in a cohort of patients...
10.
Wouters E, Stek C, Swartz A, Buyze J, Schutz C, Thienemann F, et al.
Front Psychol
. 2022 Oct;
13:983028.
PMID: 36275235
Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an important complication in patients with HIV-associated tuberculosis (TB) starting antiretroviral treatment (ART) in sub-Saharan Africa. The PredART-trial recently showed that prophylactic...